Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Urology. 2015 Sep 12;86(6):1115–1122. doi: 10.1016/j.urology.2015.07.019

Demographics and Baseline Medication use in the Cohort

TURP Laser p-value
Number of Patients 3096 3334
Age (Years) Mean 58.5
Median 60
IQR 56 to 62
Mean 58.4
Median 60
IQR 56 to 62
0.557
Follow Up Time (Days) Mean 639
Median 573
IQR 387.5 to 857
Mean 639
Median 582.5
IQR 393 to 857
0.932
Procedure Codes (Laser)
52647 340
52648 2931
60.21 63
Procedure Codes (TURP)
52450 245
52601 2745
60.0 19
60.00 0
60.2 0
60.20 0
60.29 87
Year of Surgery
  2007 27.7% 27.8% 0.933
  2008 32.4% 32.7%
  2009 39.9% 39.5%
Comorbidity 0.048
  0 75.6% 78.0%
  1 16.6% 15.5%
  ≥2 7.8% 6.5%
Medication Use 0.047
  5-alpha Reductase Inhibitor 7.85% 6.21%
  Alpha Blocker 32.62% 34.16%
Anti-spasmodic 0.94% 1.17%
  Multiple 7.56% 6.78%
  None 51.03% 51.68%